365 related articles for article (PubMed ID: 30937580)
1. Erythrocyte membrane n-3 polyunsaturated fatty acids are inversely associated with the presence and progression of nonalcoholic fatty liver disease in Chinese adults: a prospective study.
Chen ZY; Liu M; Jing LP; Xiao ML; Dong HL; Chen GD; Chen YM
Eur J Nutr; 2020 Apr; 59(3):941-951. PubMed ID: 30937580
[TBL] [Abstract][Full Text] [Related]
2. Effects of a 6-month dietary-induced weight loss on erythrocyte membrane omega-3 fatty acids and hepatic status of subjects with nonalcoholic fatty liver disease: The Fatty Liver in Obesity study.
Marin-Alejandre BA; Abete I; Monreal JI; Elorz M; Benito-Boillos A; Herrero JI; Navarro-Blasco I; Tur JA; Bandarra NM; Zulet MA; Martinez JA
J Clin Lipidol; 2020; 14(6):837-849.e2. PubMed ID: 32962964
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte membrane n-3 fatty acid levels and carotid atherosclerosis in Chinese men and women.
Dai XW; Zhang B; Wang P; Chen CG; Chen YM; Su YX
Atherosclerosis; 2014 Jan; 232(1):79-85. PubMed ID: 24401220
[TBL] [Abstract][Full Text] [Related]
4. Association between n-3 polyunsaturated fatty acids in erythrocytes and metabolic syndrome in Chinese men and women.
Dai XW; Chen YM; Zeng FF; Sun LL; Chen CG; Su YX
Eur J Nutr; 2016 Apr; 55(3):981-9. PubMed ID: 25935580
[TBL] [Abstract][Full Text] [Related]
5. Erythrocyte Membrane Polyunsaturated Fatty Acids Are Associated with Incidence of Metabolic Syndrome in Middle-Aged and Elderly People-An 8.8-Year Prospective Study.
Ding D; Li YH; Xiao ML; Dong HL; Lin JS; Chen GD; Chen ZY; Tang XY; Chen YM
J Nutr; 2020 Jun; 150(6):1488-1498. PubMed ID: 32167145
[TBL] [Abstract][Full Text] [Related]
6. Associations of serum n-3 and n-6 polyunsaturated fatty acids with prevalence and incidence of nonalcoholic fatty liver disease.
Mäkelä TNK; Tuomainen TP; Hantunen S; Virtanen JK
Am J Clin Nutr; 2022 Sep; 116(3):759-770. PubMed ID: 35648467
[TBL] [Abstract][Full Text] [Related]
7. Intake of n-3 polyunsaturated fatty acids and non-alcoholic fatty liver disease: a cross-sectional study in Japanese men and women.
Oya J; Nakagami T; Sasaki S; Jimba S; Murakami K; Kasahara T; Wasada T; Sekiguchi H; Hasegawa M; Endo Y; Iwamoto Y
Eur J Clin Nutr; 2010 Oct; 64(10):1179-85. PubMed ID: 20683463
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte ω-3 polyunsaturated fatty acids are inversely associated with the risk of oral cancer: a case-control study.
Chen Q; Wang J; Wang J; Lin J; Chen L; Lin LS; Pan LZ; Shi B; Qiu Y; Zheng XY; Chen F; He BC; Liu FQ
Nutr Diabetes; 2020 Sep; 10(1):35. PubMed ID: 32989214
[TBL] [Abstract][Full Text] [Related]
9. Association between erythrocyte membrane n-3 and n-6 polyunsaturated fatty acids and carotid atherosclerosis: A prospective study.
Ding D; Zhong QW; Zuo LS; Ling CW; Xiong F; Ke YB; Chen YM
Atherosclerosis; 2020 Apr; 298():7-13. PubMed ID: 32126389
[TBL] [Abstract][Full Text] [Related]
10. Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial.
Nogueira MA; Oliveira CP; Ferreira Alves VA; Stefano JT; Rodrigues LS; Torrinhas RS; Cogliati B; Barbeiro H; Carrilho FJ; Waitzberg DL
Clin Nutr; 2016 Jun; 35(3):578-86. PubMed ID: 26047766
[TBL] [Abstract][Full Text] [Related]
11. Serum n-3 and n-6 polyunsaturated fatty acid profile as an independent predictor of cardiovascular events in hemodialysis patients.
Shoji T; Kakiya R; Hayashi T; Tsujimoto Y; Sonoda M; Shima H; Mori K; Fukumoto S; Tahara H; Shioi A; Tabata T; Emoto M; Nishizawa Y; Inaba M
Am J Kidney Dis; 2013 Sep; 62(3):568-76. PubMed ID: 23602192
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte membrane fatty acid profile & serum cytokine levels in patients with non-alcoholic fatty liver disease.
Amirkalali B; Sohrabi MR; Esrafily A; Jalali M; Gholami A; Hosseinzadeh P; Keyvani H; Shidfar F; Zamani F
Indian J Med Res; 2018 Apr; 147(4):352-360. PubMed ID: 29998870
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
Kelley NS
Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
[TBL] [Abstract][Full Text] [Related]
14. Plasma and erythrocyte uptake of omega-3 fatty acids from an intravenous fish oil based lipid emulsion in patients with advanced oesophagogastric cancer.
Eltweri AM; Thomas AL; Fisk HL; Arshad A; Calder PC; Dennison AR; Bowrey DJ
Clin Nutr; 2017 Jun; 36(3):768-774. PubMed ID: 27342748
[TBL] [Abstract][Full Text] [Related]
15. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
[TBL] [Abstract][Full Text] [Related]
16. Plasma phospholipid n-3 and n-6 polyunsaturated fatty acids in relation to cardiometabolic markers and gestational diabetes: A longitudinal study within the prospective NICHD Fetal Growth Studies.
Zhu Y; Li M; Rahman ML; Hinkle SN; Wu J; Weir NL; Lin Y; Yang H; Tsai MY; Ferrara A; Zhang C
PLoS Med; 2019 Sep; 16(9):e1002910. PubMed ID: 31518348
[TBL] [Abstract][Full Text] [Related]
17. Low serum n-3 polyunsaturated fatty acid/n-6 polyunsaturated fatty acid ratio predicts neurological deterioration in Japanese patients with acute ischemic stroke.
Suda S; Katsumata T; Okubo S; Kanamaru T; Suzuki K; Watanabe Y; Katsura K; Katayama Y
Cerebrovasc Dis; 2013; 36(5-6):388-93. PubMed ID: 24248098
[TBL] [Abstract][Full Text] [Related]
18. Effects of plant-based versus marine-based omega-3 fatty acids and sucrose on brain and liver fatty acids in a mouse model of chemotherapy.
Ormiston K; Gaudier-Diaz MM; TinKai T; Fitzgerald J; Cole RM; Andridge R; Lustberg M; DeVries AC; Orchard T
Nutr Neurosci; 2022 Dec; 25(12):2650-2658. PubMed ID: 34772330
[TBL] [Abstract][Full Text] [Related]
19. Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.
Forouhi NG; Imamura F; Sharp SJ; Koulman A; Schulze MB; Zheng J; Ye Z; Sluijs I; Guevara M; Huerta JM; Kröger J; Wang LY; Summerhill K; Griffin JL; Feskens EJ; Affret A; Amiano P; Boeing H; Dow C; Fagherazzi G; Franks PW; Gonzalez C; Kaaks R; Key TJ; Khaw KT; Kühn T; Mortensen LM; Nilsson PM; Overvad K; Pala V; Palli D; Panico S; Quirós JR; Rodriguez-Barranco M; Rolandsson O; Sacerdote C; Scalbert A; Slimani N; Spijkerman AM; Tjonneland A; Tormo MJ; Tumino R; van der A DL; van der Schouw YT; Langenberg C; Riboli E; Wareham NJ
PLoS Med; 2016 Jul; 13(7):e1002094. PubMed ID: 27434045
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-3 PUFAs supplementation on insulin resistance and inflammatory biomarkers in hemodialysis patients.
Rasic-Milutinovic Z; Perunicic G; Pljesa S; Gluvic Z; Sobajic S; Djuric I; Ristic D
Ren Fail; 2007; 29(3):321-9. PubMed ID: 17497447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
